Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Times Interest Earned: 2012-2024

Historic Times Interest Earned for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -$662.43.

  • Sunshine Biopharma's Times Interest Earned fell 505.93% to -$238.92 in Q4 2024 from the same period last year, while for Dec 2024 it was -$65.44, marking a year-over-year decrease of 53.81%. This contributed to the annual value of -$662.43 for FY2024, which is 1800.74% down from last year.
  • As of FY2024, Sunshine Biopharma's Times Interest Earned stood at -$662.43, which was down 1,800.74% from -$34.85 recorded in FY2023.
  • Sunshine Biopharma's Times Interest Earned's 5-year high stood at -$3.43 during FY2020, with a 5-year trough of -$685.09 in FY2022.
  • Over the past 3 years, Sunshine Biopharma's median Times Interest Earned value was -$662.43 (recorded in 2024), while the average stood at -$460.79.
  • As far as peak fluctuations go, Sunshine Biopharma's Times Interest Earned plummeted by 9,131.86% in 2022, and later surged by 94.91% in 2023.
  • Sunshine Biopharma's Times Interest Earned (Yearly) stood at -$3.43 in 2020, then slumped by 116.25% to -$7.42 in 2021, then tumbled by 9,131.86% to -$685.09 in 2022, then surged by 94.91% to -$34.85 in 2023, then crashed by 1,800.74% to -$662.43 in 2024.